BridgeBio Pharma, Inc. (BBIO)
81.05
-0.45
(-0.55%)
USD |
NASDAQ |
Aug 24, 16:00
80.04
-1.01
(-1.25%)
After-Hours: 20:00
BridgeBio Pharma Total Assets (Quarterly) : 1.217B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.217B |
| March 31, 2026 | 1.371B |
| December 31, 2025 | 936.02M |
| September 30, 2025 | 998.25M |
| June 30, 2025 | 1.080B |
| March 31, 2025 | 881.64M |
| December 31, 2024 | 919.34M |
| September 30, 2024 | 664.98M |
| June 30, 2024 | 794.38M |
| March 31, 2024 | 849.33M |
| December 31, 2023 | 546.38M |
| September 30, 2023 | 655.01M |
| June 30, 2023 | 503.66M |
| March 31, 2023 | 625.68M |
| December 31, 2022 | 623.04M |
| September 30, 2022 | 728.74M |
| Date | Value |
|---|---|
| June 30, 2022 | 862.23M |
| March 31, 2022 | 813.15M |
| December 31, 2021 | 1.013B |
| September 30, 2021 | 781.52M |
| June 30, 2021 | 1.081B |
| March 31, 2021 | 1.093B |
| December 31, 2020 | 703.59M |
| September 30, 2020 | 787.69M |
| June 30, 2020 | 905.23M |
| March 31, 2020 | 989.80M |
| December 31, 2019 | 631.68M |
| September 30, 2019 | 640.53M |
| June 30, 2019 | 325.54M |
| March 31, 2019 | 401.37M |
| December 31, 2018 | 464.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Pfizer Inc. | 201.13B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| BioMarin Pharmaceutical, Inc. | 11.72B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.723B |
| Shareholders Equity (Quarterly) | -2.515B |
| Debt to Equity Ratio | -1.353 |
| Current Ratio | 1.227 |
| Net Debt Paydown Yield | -1.44% |